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Abstract
Background: Saikosaponin d (SSd) is one of the main active triterpene saponins in Bupleurum falcatum. It has a
steroid-like structure, and is reported to have pharmacological activities, including liver protection in rat, cell
cycle arrest and apoptosis induction in several cancer cell lines. However, the biological functions and molecular
mechanisms of mammalian cells under SSd treatment are still unclear.
Methods: The cytotoxicity and apoptosis of hepatic stellate cells (HSCs) upon SSd treatment were discovered by
MTT assay, colony formation assay and flow cytometry. The collage I/III, caspase activity and apoptotic related
genes were examined by quantitative PCR, Western blotting, immunofluorescence and ELISA. The mitochondrial
functions were monitored by flow cytometry, MitoTracker staining, ATP production and XF24 bioenergetic assay.
Results: This study found that SSd triggers cell death via an apoptosis path. An example of this path might be
typical apoptotic morphology, increased sub-G1 phase cell population, inhibition of cell proliferation and activation
of caspase-3 and caspase-9. However, the apoptotic effects induced by SSd are partially blocked by the caspase-3
inhibitor, Z-DEVD-FMK, suggesting that SSd may trigger both HSC-T6 and LX-2 cell apoptosis through caspase-3-
dependent and independent pathways. We also found that SSd can trigger BAX and BAK translocation from the
cytosol to the mitochondria, resulting in mitochondrial function inhibition, membrane potential disruption. Finally,
SSd also increases the release of apoptotic factors.
Conclusions: The overall analytical data indicate that SSd-elicited cell death may occur through caspase-3-
dependent, caspase-3-independent and mitochondrial pathways in mammalian HSCs, and thus can delay the
formation of liver fibrosis by reducing the level of HSCs.
Background
Hpatic stellate cells (HSCs) play important roles in vita-
min A metabolism and extracellular matrix (ECM) pro-
duction. During liver injury progression, HSCs may be
activated directly or indirectly by cytokines or reactive
oxygen species (ROS) released from injured cells. These
microenviromental activations trigger quiescent HSCs to
undergo phenotypical transformation and develop a
myofibroblast-like phenotype. Activated HSCs produce
type I and III collagen; express α-smooth muscle actin
(α-SMA), and display a high proliferation rate, ECM
synthesis, chemotaxis and cytokine release [1, 2]. Most
studies on HSCs focus on proliferation inhibition and
apoptosis induction, and some on cell migration and
relevant mechanisms.
Bupleurum falcatum has been used in traditional
Chinese medicine to treat liver injury for thousands of
years. As the major active component of triterpene
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saponin in Bupleurum falcatum, SSd has a common
steroid-like structure, and is reported to have pharmaco-
logical activities [3–7]. In particular, accumulating evi-
dence has indicated that SSd could protect against CCl4-
and dimethylnitrosamine-induced liver injury in rats [5,
8, 9]. Recent studies have indicated that SSd induces cell
cycle arrest and apoptosis in several cancer cell lines via
modulating following factors, including p53, nuclear
factor kappa B and Fas/Fas ligands [10–14]. Moreover,
SSd promotes apoptosis and G1-phase cell cycle arrest
in undifferentiated thyroid carcinoma through the up-
regulation of p53, BAX and p21, and down-regulation of
Bcl-2, CDK2 and cyclin D1 expression [15]. SSd also
sensitizes cancer cells to cisplatin through ROS-
mediated apoptosis, and prevents carcinogen-induced
tumorigenesis [16]. Our previous report showed that
SSd inhibited the proliferation of HSC-T6 cells, wound
healing and cell migration. Additionally, SSd triggers
HSC-T6 apoptosis, and blocks platelet-derived growth
factor (PDGF)-BB- and tumor growth factor (TGF)-β1-
induced cell proliferation and migration [17]. However,
the precise mechanisms underlying SSd-induced HSC
apoptosis are still not clear.
This study elucidates the mechanism underlying SSd-
induced cell death in HSCs via caspase-dependent and
caspase-independent pathways. The role of mitochon-
drial fractures in apoptosis is also examined.
Method
Cell culture and cell proliferation assay
A human HSC cell line, LX-2 was purchased from
MERCK MILLIPORE (SCC064). A rat HSC cell line,
HSC-T6, immortalized with the large T antigen of the
SV40. Both cell lines were cultured at 37 °C under a 5 %
CO2 atmosphere and in Dulbecco’s modified Eagle’s
medium (DMEM; Gibco®, Life Technologies) supple-
mented with 100U/mL penicillin, 100 μg/mL strepto-
mycin and 5 % heat-inactivated fetal bovine serum
(FBS; Gibco®, Life Technologies). The HSC-T6 and LX-
2 cells were seeded in 96-well plates at a density of 5 ×
103 cells/well in DMEM supplemented with 5 % FBS.
Following an 18-h incubation at 37 °C under a 5 % CO2
atmosphere, the old medium was replaced with fresh
DMEM/1%FBS containing SSd (1 μM). After 0, 18, 24,
48 and 72 h of incubation, the 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Invi-
trogen™, Life Technologies) was performed for cell pro-
liferation detection as describe previous report [18].
The generated formazan products were solubilized with
100 μL of dimethyl sulfoxide (DMSO; Sigma-Aldrich),
and the optical density was determined at 570 nm using
an enzyme-linked immunosorbent (ELISA) reader (infinite
M200PRO, TECAN).
Colony formation assay
Colony formation assay was performed according to
Park et al.’s work [19, 20]. Both HSC-T6 and LX-2 cells
were seeded (2 × 103 cells/well) in a 6-well plate and
incubated at 37 °C under a 5 % CO2 atmosphere for
14 days. The colonies were fixed with 70 % ethanol at
4 °C and stained with 5 % Gentian Violet (Sigma) at
room temperature.
Detection of apoptosis
Specific apoptosis was evaluated in both HSC-T6 and
LX-2 cells by treating with SSd (1 μM) for 24 h. All liv-
ing cells and cell debris were collected and fixed in 70 %
ethanol/phosphate-buffered saline (PBS) at 4 °C, pelleted
and resuspended in a buffer solution containing 200 μg/
mL RNase A and 0.01 mg/mL propidium iodide (PI;
Sigma-Aldrich). The cell cycle states of the HSC-T6 and
LX-2 cells were determined by flow cytometry (Cytomic
FC 500, BECKMAN COULTER).
Protein detection of collagen, caspase-3/7 and caspase-9
Both HSC-T6 and LX-2 cells were seeded in a 6-well
culture plate at a density of 2 × 105 cells/well to deter-
mine the protein expression levels of collagen type I, col-
lagen type III, caspase-3 and caspase-9. After 16-h
incubation, the exhausted culture medium was discarded
and replaced with fresh serum-free DMEM (Gibco®, Life
Technologies) containing SSd at a working concentra-
tion of 1 μM). The culture medium and living cells were
collected after subsequent 24-h incubation. The cell
pellet was lysed by RIPA solution, and the total protein
content was extracted. The protein expressions of
collagen type I and III, caspase-3, and caspase-9 were
measured by ELISA kits (Uscn Life Science Inc.). The
activity of caspase-3/7 and caspase-9 was measured by
the ApoTox-Glo™ Triplex assay kit (for caspase-3/7 ac-
tivity detection; Promega) and Caspase-Glo® 9 assay kit
(for caspase-9 activity detection; Promega) according to
the manufacturer’s (protocol TRY instructions). The
ApoTox-Glo™ Triplex assay kit also provides informa-
tion on apoptosis. HSC-T6 and LX-2 cells were treated
by SSd (0 μM, 0.1 μM, 0.25 μM, 0.5 μM, 1 μM, 1.5 μM,
and 2 μM) for 24 h, and the results from 3 reactions at
each SSd concentration were averaged. The fluorescence
was measured by an ELISA reader (Fluoroskan Ascent
FL, THERMO SCIENTIFIC), and the luminescence was
measured by a luminometer (Centro LB 960, CBERT-
HOLD TECHNOLOGIES).
RNA isolation and quantitative RT-PCR
Total RNA was isolated by TriPure Isolation Reagent
(Roche) based on the manufacturer’s protocol. Reverse
transcriptional PCR was performed using the iScripe™
cDNA Synthesis kit (BIO-RAD). Quantitative polymerase
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chain reaction (qPCR) analysis and data collection were
performed by an ABI 7500 FAST (Applied Biosystem).
The following sequences of specific primers of target













Mitochondrial and cytosolic fractions isolation and
protein detection
HSC-T6 cells (1 × 107 cells) were treated with SSd
(1 μM) for 0, 0.25, 0.5, 1, 2, 4, and 8 h. Their mitochon-
drial and cytosolic fractions were then isolated by a
Mitochondria/Cytosol Fractionation Kit (BioVision).
Protein expression was detected by Western blotting
using specific antibodies. The protein levels of COX3,
GAPDH, BAX, BAK, apoptotic-protease-activating fac-
tor (Apaf)-1, cytochrome c (Cyt c), endonuclease G
(EndoG) and apoptosis-inducing factor (AIF) were deter-
mined in isolated mitochondrial and cytosolic fractions
(25 μg).
Western blotting
The cells were subsequently lysed in RIPA solution con-
taining protease inhibitors (Roche). The total extracted
protein content (25 μg) was separated by SDS-PAGE
and transferred to polyvinyl difluoride (PVDF) mem-
branes. The PVDF membranes were incubated by
primary antibodies at a dilution of 1:500 or 1:1000 to
detect procaspase-9, caspase-9, procaspase-3, caspase-3
(Cell Signalling), COX3, GAPDH (Santa Cruz), collagen
I, collagen III, BAX, BAK, Bcl-2, Bcl-xL, Bcl-2-associated
death promoter (BAD), p53 upregulated modulator of
apoptosis (PUMA), β-actin, Apaf-1, Cyt c, EndoG, AIF
(GeneTex) and α-SMA (abcam). The fold change in pro-
tein expression was expressed as a ratio calculated by
dividing the specific protein band density by the β-actin
band density.
Mitochondrial membrane potential change measurement
and mitochondrial staining
The mitochondrial membrane potential (Δψm) during
apoptosis was monitored by a MitoProbe JC-1 assay kit
(Molecular Probe), which is a lipophilic cationic dye. In
brief, HSC-T6 cells were exposed to SSd (1 μM) for 30
and 60 min, and the cells were subsequently labeled with
2 μM JC-1 dye for 30 min at 37 °C. All cells were col-
lected, washed twice with PBS, and analyzed by flow cy-
tometry (Cytomic FC 500, BECKMAN COULTER). For
mitochondrial staining, HSC-T6 cells were grown on
coverslips for 16 h. After treatment with 1 μM SSd for 0,
15, 30 and 60 min, mitochondria were stained with
100nM MitoTracker® Deep Red FM (Invitrogen™, Life
Technologies) for 30 min at 37 °C. DAPI (Molecular
Probe) was adopted as a nuclear counterstain, and im-
ages were acquired by a confocal laser-scanning micro-
scope (TCS SP5, LEICA).
ATP production, oxygen consumption, and extracellular
acidification detection
Cellular ATP levels were detected by the Mitochondrial
ToxGlo assay (Promega) according to the manufacturer’s
protocol. Briefly, HSC-T6 cells were cultured at 1 × 104
cells/well in a white, clear-bottom 96-well culture plate.
The culture was incubated for 16 h, then the exhausted
medium was discarded and replaced with a fresh
medium containing 10 mM galactose instead of glucose.
The cells were subsequently treated with SSd (0 μM,
0.1 μM, 0.25 μM, 0.5 μM, 0.75 μM, 1 μM, 1.5 μM, and
2 μM) for 24 h. An equal volume of the assay solution
was added to each well, and the plate was subsequently
incubated at room temperature for 30 min. Lumines-
cence was measured by a luminometer (Centro LB 960,
CBERTHOLD TECHNOLOGIES). The cellular oxygen
consumption rate (OCR) and extracellular acidification
rate (ECAR) were measured by an XF24 bioenergetic
assay (Seahorse Bioscience, Billerica, MA). Briefly, HSC-
T6 cells were suspended in DMEM containing 5 % FBS
and seeded on an XF24 microplate. The culture was in-
cubated for 2 days, then the XF24 bioenergetic assay
was initiated by removing the exhausted medium and re-
placing it with sodium-bicarbonate-free DMEM contain-
ing 5 % FBS. The extracellular flux changes in oxygen
and in the pH of the medium surrounding the adherent
cells were detected instantaneously by an XF24 extracel-
lular Flux Analyzer (Seahorse Bioscience). The OCR and
ECAR were detected at a steady state, then SSd (0.5 μM
and 1 μM), oligomycin (1 μM), carbonyl cyanide 4-[tri-
fluoromethoxy] phenylhydrazone (FCCP; 1 μM) and a
mixture of rotenone (1 μM) and myxothiazol (1 μM)
were injected sequentially into the wells to obtain the
values of the maximal and non-mitochondrial respir-
ation rate.
Immunofluoresence staining
HSC-T6 cells were grown on coverslips in 24-well plates
and incubated overnight. The cells were treated with
SSd (1 μM) for 1 h, then stained with 100nM Mito-
Tracker® Deep Red FM (Invitrogen™, Life Technologies)
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for 30 min at 37 °C. The cells were then fixed with 4 %
cold paraformaldehyde for 20 min at 4 °C, and perme-
abilized with 0.1 % Triton X-100 for 1 min at room
temperature. The cells were subsequently blocked with
1 % bovine serum albumin (BSA) for 30 min at room
temperature and incubated with anti-Cyt c, anti-EndoG
and anti-AIF antibody (GeneTex) overnight at 4 °C. The
cells were then incubated with FITC-conjugated second-
ary antibody (Santa Cruz Biotechnology) for 60 min at
room temperature, with DAPI (Molecular Probe) as a
nuclear counterstain. The coverslips were mounted onto
microscopy slides, and visualized under a confocal laser-
scanning microscope (TCS SP5, LEICA).
Statistical analyses
All data are shown as the means of 3 independent exper-
iments (mean ± S.D.). Statistical analysis was performed
by the unpaired Student’s t-test, with p < 0.01 as
significant.
Results
SSd induced apoptosis, and reduced the protein
expression of collagen I, collagen III and α-SMA in HSCs
To study the cytotoxic effects of SSd on HSCs of both
HSC-T6 and LX-2, the MTT assay and colony formation
assay were performed to examine the cell growth after
exposure to SSd. SSd effectively inhibited cell prolifera-
tion of both HSC-T6 and LX-2 cells in a time-dependent
manner (Fig. 1a). Additionally, SSd (0.5 μM and 1 μM)
inhibited colony formation of both HSC-T6 and LX-2
cells (Fig. 1b). Numerous cell debris suddenly appeared
when cells were treated with SSd (1 μM) at 72 h (Fig. 1c).
Flow cytometry was analyzed to detect apoptotic signals
(i.e., the sub-G1 phase of the cell cycle) after SSd
Fig. 1 SSd inhibited cell proliferation and colony formation, induced apoptosis, and reduced α-SMA expression on HSC-T6 and LX-2 cells. (a)
HSC-T6 and LX-2 cells were treated with SSd (1 μM) for 0, 16, 24, 48 and 72 h. Cell proliferation rate was detected by the MTT assay. (b) SSd inhib-
ited HSCs cell growth as determined by colony formation assay. (c) Cell morphology was visualized by an optical microscope with magnification:
200×. Apoptotic cells of both HSC-T6 (d) and LX-2 cells (e) were detected by flow cytometry. (f) The α-SMA protein was measured in HSCs treated
with a variety of SSd doses by Western blotting. Data are the mean ± S.D. from 3 independent experiments
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treatment for 24 h. As indicated in Fig. 1d and e, the
percentage of the sub-G1 phase and apoptotic bodies in-
creased in both HSC-T6 and LX-2 cells treated with
SSd. Activated HSCs are characterized by their expres-
sion of α-SMA and the synthesis of ECM constituents,
particularly collagen I and III, during hepatic fibrosis [2,
21]. Our data indicate that SSd significantly reduced α-
SMA expression in both HSC-T6 and LX-2 cells (Fig. 1f ).
Additionally, SSd markedly reduced collagen I and III
expression within 72 h in both HSC-T6 and LX-2 cells
by Western blotting and ELISA (Fig. 2a-d).
The SSd-induced apoptotic effects on HSC-T6 and LX-2
cells were partially caspase-3-dependent
Caspase activity induction is involved in several ligand-
and chemical-induced apoptotic processes. SSd treat-
ment detected caspase-3/7 and caspase-9 activities in
HSCs by using the ApoTox-Glo Triplex assay, Caspase-
Glo 9 assay and Western blotting. The cytotoxicity,
caspase-3/7 activity and caspase-9 activity of both HSC-
T6 and LX-2 cells were increased, after treated with SSd
for 24 h, as indicated in Fig. 3. Western blotting results
also indicated that levels of caspase-3- and caspase-9-
activated fragments rose after SSd treatment (Fig. 4a).
To assess whether the total endogenous protein levels of
caspase-3 and -9 were altered, the total forms of
caspase-3 and -9 were measured by ELISA. Analytical
results indicate that treatment with SSd for 24 h did not
alter the total protein levels of caspase-3 and -9 com-
pared to control groups in either HSC-T6 or LX-2 cells
(Fig. 4b and c). A caspase-3 inhibitor, Z-DEVD-FMK,
was adopted applied to investigate whether SSd-induced
apoptosis was caspase-3-dependent. HSC-T6 and LX-2
cells were pre-incubated with Z-DEVD-FMK (100nM)
Fig. 2 SSd inhibited the collagen I and III expression and secretion in HSC-T6 and LX-2 cells. (a and b) HSC-T6 and LX-2 cells were treated with or
without SSd (1 μM) for 0, 24, 48 and 72 h. The total cellular protein content was extracted to measure the collagen type I and type III expression
by western blotting. The fold change in protein expression is expressed as a ratio calculated by dividing the specific protein band density by the
β-actin band density. The supernatant was collected to measure the secreted collagen type I (c) and collagen type III (d) by ELISA. *P < 0.01 versus
time zero or the control group
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for 1 h, and were subsequently co-treated with SSd for
24 h. Experimental results indicate that Z-DEVD-FMK
partially inhibited the SSd-induced sub-G1 phase and
cytotoxicity, as measured by flow cytometry and the
MTT assay (Fig. 4d-f ). These data indicate that SSd-
induced apoptosis of both HSC-T6 and LX-2 cells may
occur partially via caspase-3-dependent.
SSd reduced ATP production, mitochondrial function and
metabolism in HSC-T6 cells
Mitochondrial fracture is common in apoptotic pro-
cesses, and results in apoptotic factor release and
caspase-9 activation. An experiment was performed to
measure ATP production in HSC-T6 cells using the
Mitochondrial ToxGlo Assay. Treatment with the indi-
cated concentrations of SSd reduced cellular ATP pro-
duction (Fig. 5a). To assess SSd-induced changes in the
cells’ metabolic capacity and extracellular acidification,
the cellular oxygen consumption and extracellular acid-
ification were measured simultaneously by the Seahorse
XF24 system. The steady-state oxygen consumption and
extracellular acidification were measured, and then SSd
(0.5 μM or 1 μM) was injected into the system at the
fourth time point to stimulate the cells. Oligomycin was
then injected to inhibit ATP synthase, and FCCP was
added by injection to assess the maximal oxygen
consumption. Finally, a mixture of rotenone and
myxothiazol was injected to confirm that the respiration
changes were mainly due to altered mitochondrial res-
piration. Experimental data show that SSd (1 μM) re-
duced levels of OCR and ECAR significantly (Fig. 5b and
c). Injection of 0.5 μM of SSd has no effect on OCR at
the fifth time point after, but it significantly inhibited
ECAR (Fig. 5d and e). These results may indicate that
SSd reduces oxygen consumption and the mitochondrial
metabolic capacity of HSC-T6 cells.
SSd regulated pro-apoptotic and anti-apoptotic protein
expressions, and changed the mitochondrial membrane
potential, resulting in mitochondrial apoptotic factor
release
After SSd treatment, the total protein content of HSC-
T6 cells was extracted, and the expression of BAK, BAD,
BAX, PUMA, Bcl-2 and Bcl-xL with specific antibodies
was detected. SSd upregulated the BAK, BAD, and
PUMA expressions within 8 h (Fig. 6a). Conversely, SSd
downregulated the Bcl-2 expression, but did not affect
the BAX or Bcl-xL expressions. The RNA expression
levels of BAX, BAD, Bcl-2, and PUMA were consistent
with the protein profiles (Fig. 6b). During apoptosis,
BAX and BAK translocate from the cytoplasm to the
mitochondria to form BAX/BAK pores. These BAX/
BAK pores disturbed the membrane potential, leading to
mitochondrial fracture and apoptotic factor release. To
Fig. 3 SSd induced cytotoxicity accompanied by an increase in caspase-3/7 and caspase-9 activity. (a) After treatment with serial concentrations
of SSd for 24 h, cell survival of, cytotoxicity against, and caspase-3/7 activity in HSC-T6 cells were detected by an ApoTox-Glo™ Triplex assay kit.
Caspase-9 activity was detected by a Caspase-Glo® 9 assay kit. (b) The same experiments described were performed in LX-2 cells. The data are the
mean ± S.D. from 3 independent experiments
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determine the effects experimentally, HSC-T6 cells were
exposed to SSd (1 μM) exposure for 15, 30 and 60 min,
and the mitochondrial and cytosolic fractions were then
isolated for BAK and BAX detection. The organelle-
specific marker COX3 expression was detected by West-
ern blotting to ensure the purity of mitochondria [22].
As indicated in Fig. 7a, COX3 was present significantly
in the mitochondrial fraction, while cytosol marker
GAPDH was absent. BAK and BAX could be detected in
the mitochondrial fraction of the 30- and 60-min SSd-
treated cells (Fig. 7b). Additionally, GAPDH was present
in the cytosolic fraction, but not in the mitochondrial
fraction (Fig. 7c). SSd reduced BAK and BAX expres-
sions in the cytosolic fraction within 60 min (Fig. 7d).
The high purity of the mitochondria ensured that SSd
increased BAK and BAX expression in mitochondria,
while reducing it in cytoplasm. Moreover, the mitochon-
drial membrane potential and MitoTracker® Deep Red
FM staining signal fell after SSd treatment (Fig. 7e and
f). To further study the effect of SSd on apoptotic factor
release, the mitochondrial and cytosolic fractions were
isolated from HSC-T6 cells after SSd treatment. The
purity of the mitochondrial and cytosolic fraction was
also confirmed by the specific markers COX3 and
GAPDH (Fig. 8a and b). Following SSd-induced mito-
chondrial function impairment, the mitochondial con-
tent of apoptotic factors, including Cyto c, EndoG, and
AIF, fell while the cytoplasmic content of apoptotic fac-
tors rose (Fig. 8c and d). In addition, the apoptotic factor
staining signal and mitochondrial staining signal fell
after the 60-min SSd treatment, as revealed by fluores-
cent immunocytochemical staining and MitoTracker®
Fig. 4 The SSd-induced apoptotic effects on HSC-T6 and LX-2 cells were partially caspase-3-dependent. (a) HSC-T6 and LX-2 cells were treated
with SSd (1 μM) for 0, 8, 12 and 24 h, and the total cellular protein content was subsequently extracted to detect the pro-caspase-3, pro-caspase-
9, caspase-3 and caspase-9 expression. The expression level of active caspase-3 and caspase-9 increased. (b and c) The protein expression level
of caspase-3 and caspase-9 was also detected by ELISA kits. (d and e) HSC-T6 cells were treated with SSd (1 μM) for 24 h, and subsequently fixed
by 70 % alcohol. The cells were stained with PI, and the cell cycle distribution was detected by flow cytometry. LX-2 cells were also treated with
SSd (1 μM) for 24 h, and cell cycle distribution was detected by flow cytometry. The SSd-induced sub-G1 phase of HSC-T6 and LX-2 was partially
inhibited by the caspase-3 inhibitor Z-DEVD-FMK. (f) SSd-induced cytotoxicity was detected by the MTT assay, and was also partially impeded by
Z-DEVD-FMK. *P < 0.01
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Deep Red FM staining (Fig. 8e). These results suggest
that SSd regulates pro- and anti-apoptotic protein ex-
pression and triggers BAX and BAK translocation,
resulting in decrease of mitochondrial membrane poten-
tial, and apoptotic factor release.
Discussion
The liver injury process may lead to HSC activation and
high levels of α-SMA and collagen type I and III [2, 21].
Some previous studies have indicated that SSd protects
liver function from CCl4- and dimethylnitrosamine-
induced injury in rats [5, 8, 9]. These reports indicate
that SSd-treated strategy for liver fibrosis may be safe,
avoiding normal tissue injury. In our previous study, SSd
inhibited HSC-T6 cell proliferation and migration. This
study found that SSd induced apoptosis, and reduced α-
SMA, collagen type I and collagen type III expression in
HSC-T6 and LX-2 cells. Additionally, SSd-induced
apoptosis was partially caspase-3 dependent. This is the
first study to show that SSd-induced apoptosis on HSCs
can be either caspase-3-dependent or caspase-3-
independent. Moreover, our results also indicate that
SSd triggers BAX/BAK translocation and apoptotic fac-
tor release. These data suggest that SSd inhibits HSCs
activity and induces apoptosis. We conclude that SSd
has potential for liver fibrosis treatment.
Mitochondria are essential cellular organelles that play
a central role in ATP production and cell survival. How-
ever, mitochondria may also act as a regulator of the
intracellular apoptotic pathway [23], and therefore have
been considered as a potential target for chemotherapy.
In this study, mitochondrial activity was estimated by a
lumino- and XF24-bioenergetic assay. ATP production
significantly fell after SSd treatment (Fig. 5a). Moreover,
experimental data obtained by the XF24 bioenergetic
assay indicate that SSd reduced the OCR of HSC-T6
cells at 0.5 μM, and almost completely inhibited it at a
concentration of 1 μM (Fig. 5b). Oligomycin (an ATP
synthase inhibitor) and FCCP (a proton ionophore) were
injected into the cell culture microplate wells to assess
Fig. 5 SSd blocked ATP production, mitochondrial oxygen consumption and extracellular acidification of HSC-T6 cells. (a) HSC-T6 cells were
treated with a series of SSd concentrations, and the subsequent cellular ATP production was detected by the Mitochondrial ToxGlo assay. (b and
c) The oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were detected by a Seahorse XF24 bioenergetic assay. The arrow
points denote the injection of SSd, oligomycin (Oligo), FCCP and rotenone/myxothiazol (AA). Steady-state OCR and ECAR were measured before
the SSd injection. Oligomycin was injected at the twelfth time point, while maximal oxygen consumption was measured at the fifteenth time
point after FCCP injection. (d and e) The data of the 5th time point of OCR and ECAR after SSd injection indicate that SSd (0.5 μM) had stronger
inhibitory effects on ECAR than on OCR. The data are the mean ± S.D. from 3 independent experiments. *P < 0.01 versus the control group
Chen et al. BMC Cancer  (2016) 16:532 Page 8 of 12
the maximal OCRs. Finally, a mixture containing rote-
none (an inhibitor of mitochondrial complex I) and
myxothiazol (an electron transport blocker) was injected
into the cell culture wells to confirm that the respiration
changes resulted mainly from altered mitochondrial
respiration. These data indicate that SSd significantly
blocked the effect of FCCP (Fig. 5b) and might have
inhibited ATP synthase, damaged the mitochondrial
membrane and blocked the electron transport system
in HSC-T6 cells. Extracellular acidification was de-
tected simultaneously with oxygen consumption. The
ECAR measurements reflected the metabolic activity
of the HSC-T6 cells. Notably, SSd (0.5 μM) had a
greater inhibitory effect on ECAR than on OCR
(Fig. 5d and e). These data indicate that metabolism
suppression may play a more important role in SSd-
induced cell death and proliferation inhibition. A fu-
ture study will investigate the underlying mechanism
for this phenomenon.
Mitochondria-dependent apoptosis is regulated by the
opposing actions of pro- and anti-apoptotic proteins of
the Bcl-2 family, such as BAX and BAK that translocate
from the cytosol to the mitochondrial outer membrane
upon death signal stimulation. The translocated BAX
and BAK subsequently form permeability transition
pores, leading to apoptotic factor release and mitochon-
dria rupture. Conversely, Bcl-2 and Bcl-xL, two anti-
apoptotic proteins of the Bcl-2 family, inhibit BAX/BAK
permeability transition pore formation and preserve
mitochondrial integrity [24–26]. BAD is another pro-
apoptotic protein of the Bcl-2 family involved in initiat-
ing apoptosis. It forms a heterodimer with Bcl-2 and
Bcl-xL after activation, preventing them from arresting
apoptosis [27]. Moreover, the pro-apoptotic Bcl-2 family
protein PUMA is regulated by the tumor suppressor
p53. After death signal stimulation, PUMA blocks
the function of anti-apoptotic proteins, such as Bcl-
2, Bcl-xL, Mcl-1 and Bcl-w, resulting in BAX/BAK
Fig. 6 SSd reduced Bcl-2 expression, and increased BAK, BAD and PUMA expression. (a) HSC-T6 cells were treated with or without SSd (1 μM) for
0, 4 and 8 h. The total extracted protein content was analyzed by Western blotting to assess the protein expression of Bcl-2, Bcl-xL, BAX, BAK,
BAD, and PUMA. (b) The total RNA of the HSC-T6 cells was extracted and quantified after treatment with or without SSd (1 μM) for 0 and 1 h. Re-
verse transcription PCR was performed with 3 μg of total RNA were used for. Bcl-2, Bcl-xL, BAX, BAK, BAD, PUMA and GAPDH cDNA were amplified
and quantified using an ABI 7500 Real Time PCR System. *P < 0.01 versus the control group
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translocation, apoptotic factor release, caspase activa-
tion and cell death [28]. The expression levels of pro-
and anti-apoptotic proteins were measured to investi-
gate mitochondria-dependent SSd-induced apoptosis.
The levels of BAK, BAD, and PUMA increased,
whereas that of Bcl-2 fell (Fig. 6).
Cyto c and Apaf-1, the main apoptotic factors, have
essential roles in the mitochondria-dependent apoptotic
pathway and trigger caspase activation in mammalian
cells. Death signal stimulation causes the release of Cyto
c and Apaf-1 from the mitochondria into the cytosol,
leading to activation of caspase-9. Subsequently, pro-
caspase-3 is converted to its active form (caspase-3) by
caspase-9-mediated cleavage. Caspase-3 splits poly-ADP
ribose polymerase (PARP) to cause DNA fragmentation
and apoptosis [23]. Hence, the activation of caspase-3
can be considered as an important molecular marker for
apoptosis. Moreover, mitochondria can also release AIF
and EndoG to initiate caspase-3-independent apoptosis.
During apoptotic signal stimulation, AIF and EndoG are
released from the mitochondria, and translocate to the
nucleus where they induce apoptosis by triggering chro-
matin condensation and DNA fragmentation [1, 29, 30].
This study found that SSd-induced apoptosis is partially
caspase-3 dependent (Fig. 4). SSd also significantly re-
duced ATP production and mitochondrial function
(Fig. 5). Additionally, BAX and BAK were detected in
the mitochondrial fraction, while SSd reduced expres-
sions of these two proteins in cytosolic fractions (Fig. 7b).
Furthermore, the mitochondrial membrane potential
and the MitoTracker signal declined in SSd-treated
HSC-T6 cells (Fig. 7e and f). Finally, that the cytosolic
protein fraction levels of Apaf-1, Cyt c, AIF, and EndoG
increased (Fig. 8d). Taken together, these data indicate
Fig. 7 SSd triggered BAX and BAK translocation, and reduced the mitochondrial membrane potential. (a) HSC-T6 cells were treated with SSd
(1 μM) for 0, 15, 30 and 60 min. The purity of mitochondrial fraction was validated by Western blotting with specific antibodies of mitochondria
marker COX3 and cytosolic marker GAPDH. (b) SSd increased BAK and BAX expression in the mitochondrial fraction. (c) Cytosolic proteins were
also applied to Western blotting. COX3 and GAPDH were also detected to validate the purity of the cytosolic fraction. (d) SSd reduced BAK and
BAX expression in the cytosolic fraction. (e) The mitochondrial membrane potential (Δψm) was monitored using a MitoProbe JC-1 assay kit, and
was analyzed by flow cytometry. (f) HSC-T6 cells were grown in 24-well chamber cover glasses; treated with 1 μM SSd for 0, 15, 30 and 60 min,
and analyzed using a confocal laser scanning microscope. Mitochondria were stained by the mitochondria-specific probe MitoTracker® Deep Red
FM (100nM)
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that SSd may trigger BAX and BAK translocation, result-
ing in a potential decrease in mitochondrial membrane
levels, and release of apoptotic factors.
Conclusion
In conclusion, SSd may induce caspase-3-dependent and
independent apoptosis, which are mediated by mito-
chondrial dysfunction and fracture. Our work further
reveals that Cyt c, Apaf-1, AIF, and EndoG may be in-
volved in SSd-induced apoptosis.
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Fig. 8 SSd triggered apoptotic factor release in HSC-T6 cells. The mitochondrial (a) and cytosolic (b) fractions were isolated following the treat-
ment of HSC-T6 cells with 1 μM SSd. The purities of mitochondrial and cytosolic fraction were validated with anti-COX3 and anti-GAPDH anti-
bodies by Western blotting. The expression levels of Apaf-1, Cyt c, EndoG and AIF were detected by Western blotting with specific antibodies in
mitochondrial (c) and cytosolic (d) fractions. (e) HSC-T6 cells were grown in 24-well chamber cover glasses; treated with 1 μM SSd for 60 min;
stained with MitoTracker® Deep Red FM (100 nM) for 30 min; fixed with 4 % cold paraformaldehyde, and incubated with specific primary anti-
bodies and FITC-conjugated secondary antibody. DAPI was adopted as a nuclear counterstain. The fluorescence signals were analyzed by confocal
laser scanning microscopy
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